Primary pulmonary mucoepidermoid carcinoma: an analysis of 21 cases
Open Access
- 1 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 10 (1), 232
- https://doi.org/10.1186/1477-7819-10-232
Abstract
Background The optimal treatment for pulmonary mucoepidermoid carcinoma (MEC), a rare type of tumor, has not been established yet. This study analyzed the survival of pulmonary MEC patients and attempted to find clues for optimal treatment. Methods A total of 21 patients with pulmonary MEC from November 2004 to January 2011 were included in the investigation. Immunohistochemistry, epidermal growth factor receptor (EGFR) mutation, and survival were retrospectively studied. Results Among the 21 pulmonary MEC patients, 17 were diagnosed with low-grade malignancy and 4 with high-grade malignancy through pathological examination. The prognosis was found to be poor in the presence of lymph nodes. The expression rates of EGFR and HER2 were 28.6% and 0%, respectively, which correlated with neither grade nor prognosis. The mutation rate of EGFR was 0. Log-rank test results indicated that age, grade, lymph node metastasis, and tumor-node-metastasis stage were prognostic factors. Conclusion Age, grade, lymph node metastasis and tumor-node-metastasis stage correlate with the survival of pulmonary MEC patients. Trial registration This study was approved and registered by the Ethics Committee of Zhongshan Hospital. Written informed consent was obtained from all participants prior to treatment.Keywords
This publication has 18 references indexed in Scilit:
- Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerBritish Journal of Cancer, 2011
- Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glandsBritish Journal of Cancer, 2010
- Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: Possible significance of CRTC1–MAML2 oncogeneLung Cancer, 2009
- Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatmentLung Cancer, 2008
- Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis studyLaboratory Investigation, 2008
- Systemic Therapy in the Palliative Management of Advanced Salivary Gland CancersJournal of Clinical Oncology, 2006
- Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology GroupHead & Neck, 2006
- Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cellsInternational Journal of Cancer, 2005
- HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ HybridizationMayo Clinic Proceedings, 2002
- Mucoepidermoid lung tumorsThe Annals of Thoracic Surgery, 1989